Abstract
Glycosylated hemoglobin (HbA1c) identifies the average plasma glucose concentration over 120 days. HbA1c test measurements can lead to false outcomes in patients with inherited hemoglobin variants as hemoglobin S, which is prevalent in the Middle Eastern population. Our aim was to evaluate four different methods for measuring the blood HbA1c levels in diabetic patients with sickle cell anemia (SCA) and sickle cell trait (SCT). Blood samples were collected in EDTA tubes from 38 diabetic patients with either SCA or SCT. HbA1c levels were measured on all samples at three different local hospitals using three different analyzers: the Cobas Integra700 (Roche, SZ), the Dimension RXL (Siemens, USA), and the DCA2000 (Siemens, USA). All methods were compared to the standard HPLC method Variant (Bio-Rad, USA). There was a good correlation (R 2) between HbA1c levels measured by the HPLC Variant II and immunoassay analyzers and between the immunoassay analyzers themselves in SCT, but not in SCA, patients. However, an excellent correlation was observed in the SCA group between the Dimension RXL and Cobas Integra analyzers (R 2 = 0.9918). Significant differences were observed in all the three immunoassay methods compared to the Variant HPLC (P <0.00001) and between the DCA2000+ and the Dimension RXL (P = 0.0144), as well as between the DCA2000+ and the Cobas Integra (P = 0.0247). We concluded that while HbA1c levels were undetected by some methods, other methods were able to measure HgbA1c with a high degree of accuracy. Therefore, we recommend that any affected HbA1c samples should be measured by two different methods.
Similar content being viewed by others
References
Goldstein DE, Little RR, Lorenz RA, Ma- lone JI, Nathan D, Peterson CM. Tests of glycemia in diabetes. Diabetes Care. 2000;23 Suppl 1:S80–3.
Martina WV, Martijn EG, van der Molen M, Schermer JG, Muskiet FAJ. β-N-terminal glycohemoglobins in subjects with common hemoglobinopathies: relation with fructosamine and mean erythrocyte age. Clin Chem. 1993;39:2259–65.
Frank EL, Moulton L, Little RR, Wiedmeyer HM, Rohlfing C, Roberts WL. Effects of hemoglobin C and S traits on seven glycohemoglobin methods. Clin Chem. 2000;46:864–7.
Weykamp CW, Penders TJ, Muskiet FA, van der Slik W. Influence of hemoglobin variants and derivatives on glycohemoglobin determinations, as investigated by 102 laboratories using 16 methods. Clin Chem. 1993;39:1717–23.
Smaldone A. Glycemic control and hemoglobinopathy: when A1c may not be reliable. Diabetes Spectr. 2008;21:46–9.
Malekiani CL, Ganesan A, Decker CF. Effect of hemoglobinopathies on hemoglobin A1c measurements. Am J Med. 2008;121(6):e5.
Wiwanitkit V. Problem of using hemoglobin A1c measurement in endemic area of hemoglobinopathy. Prim Care Diabetes. 2007;1:173–5.
Sacks DB. Hemoglobin variants and hemoglobin A1c analysis: problems solved? Clin Chem. 2003;49:1245–7.
A database of human hemoglobin variants and thalassemias. Available from: http://www.globin.cse.psu.edu/cgi-bin/hbvar/counter. Accessed 25/07/2011.
Bry L, Chen PC, Sacks DB. Effects of hemoglobin variants and chemically modified derivatives on assays for glycohemoglobin. Clin Chem. 2001;47:153–63.
Chu CH, Wang MC, Sun TH, Lee JK, Lam HC. Very low HbA1c values in a patient with clinical silent hemoglobin variant (Hemoglobin J): a case report. J Intern Med Taiwan. 2007;18:45–50.
Nigam PK, Sharma S, Sareen R, Paul V, Lal A. Lack of precision in HbA1c values on variant II in cases of hemoglobin Q India. Indian J Clin Biochem. 2006;21:72–5.
van den Ouweland JM, van Daal H, Klaassen CH, van Aarssen Y, Harteveld CL, Giordano PC. The silent hemoglobin alpha chain variant Hb Riccarton [alpha 51(CE9)Gly ->Ser] may affect HbA1c determination on the HLC-723 G7 analyzer. Clin Chem Lab Med. 2008;46:827–30.
Kilpatrick ES, Bloomgarden ZT, Zimmet PZ. Is hemoglobin A1c a step forward for diagnosing diabetes? BMJ. 2009;339(10):1288–90.
Schnedl WJ, Liebminger A, Roller RE, Lipp RW, Krejs GJ. Hemoglobin variants and determination of glycated hemoglobin (HbA1c). Diabetes Metab Res Rev. 2001;17:94–8.
Schnedl WJ, Krause R, Halwachs-Baumann G, Trinker M, Lipp RW, Krejs GJ. Evaluation of HbA1c determination methods in patients with hemoglobinopathies. Diabetes Care. 2000;23:339–44.
John WG, Braconnier F, Miedema K, Aulesa C, Piras G. Evaluation of the Menarini-Arkay HA 8140 hemoglobin A1c analyzer. Clin Chem. 1997;43:968–75.
Carta M, Dall’Olio G, Soffiati G. Determination of HbA1c in the presence of haemoglobin variants: comparison of three HPLC techniques. Eur J Clin Chem Biochem. 1997;35:923–5.
Weykamp CW, Penders TJ, Siebelder CW, Muskiet FA, van der Slik W. Interference of carbamylated and acetylated hemoglobins in assays of glycohemoglobin by HPLC, electrophoresis, affinity chromatography, and enzyme immunoassay. Clin Chem. 1993;39:138–42.
Chang J, Hoke C, Ettinger B, Penerian G. Evaluation and interference study of hemoglobin A1c measured by turbidimetric inhibition immunoassay. Am J Clin Pathol. 1998;109:274–8.
Roberts WL, Chiasera JM, Ward-Cook K. Glycohemoglobin results in samples with hemoglobin C or S trait: a comparison of four test systems [Technical Brief]. Clin Chem. 1999;45:906–9.
Roberts WL, De BK, Brown D, Hanbury CM, Hoyer JD, John WG, et al. Effects of Hemoglobin C and S traits on eight glycohemoglobin methods. Clin Chem. 2002;48:383–5.
Miedema K, Lenters-Westra E, Horowitz G, Pistorino A, Patel R, Ng K, et al. Evaluation of the technical feasibility of Tina-quant HbA1c Gen.2. Assay on COBAS INTEGRA 800 [Abstract]. Clin Chem. 2005;51:A234.
Wang Y, Beckwith B, Smith C, Horowitz G. Misleading glycated hemoglobin results in a patient with hemoglobin SC disease. Clin Chem. 2007;53:1394–5.
Watanabe T, Kato K, Yamada D, Midorikawa Sato W, Shiga M, Otsuka Y, et al. A nondiabetic case of hemoglobin variant (Hb Nigiata) with inappropriately high and low HbA1c titers detected by different methods. Clin Chem. 1998;44:1562–4.
Roberts WL, Safar-Pour S, De BK, Rohlfing CL, Weykamp CW, Little RR. Effects of hemoglobin C and hemoglobin S traits on glycohemoglobin measurements by eleven methods. Clin Chem. 2005;51:776–8.
Mongia SK, Little RR, Rohlfing CL, Hanson S, Roberts RF, Owen WE, et al. Effects of hemoglobin C and S traits on 14 commercial glycated hemoglobin assays. Am J Clin Pathol. 2008;130:136–40.
Higgins T, Stewart D, Boehr E. Challenges in HbA1c analysis and reporting: an interesting case illustrating many pitfalls. Clin Biochem. 2008;41:1104–6.
Lee KF, Szeto YT, Benzie IFF. Glycohaemoglobin measurement: methodological differences in relation to interference by urea. Acta Diabetol. 2002;39:35–9.
Schnedl WJ et al. Determination of glycated hemoglobin in clinically silent hemoglobin variants. Diabetes Metab Res Rev. 2004;20:460–5.
Nakanishi T, Iguchi K, Shimizu H. A method for hemoglobin A1c measurement based on peptide analysis by electrospray ionization mass spectrometry with deuterium-labeled synthetic peptides as internal standards. Clin Chem. 2003;49:829–31.
Bisse E, Schauber C, Zorn N, Epting T, Eigel A, Van Dorsselaer A, et al. Hemoglobin Görwihl [α 2ß25(A2)Pro → Ala], an electrophoretically silent variant with impaired glycation. Clin Chem. 2003;49:137–43.
Friess U, Beck A, Kohne E, Lehmann R, Koch S, Haring H-U, et al. Novel hemoglobin variant [ß66(E10) Lys → Asn], with decreased oxygen affinity, causes falsely low hemoglobin A1c values by HPLC. Clin Chem. 2003;49:1412–5.
Acknowledgments
We would like to thank the staff at King Abdullah International Medical Research Center (KAIMRC) and King Saud bin Abdulaziz University for Health Sciences (KSAU-HS) for supporting this project. We would also like to thank the laboratory and nursing staff of King Fahad National Guard Hospital for supporting this project. Special thanks to Mr. Omar Alhazza, Mr. Abdullah Alshargroud, and Mr. Mohammed Alomran from the Information Service Department ISD for their help and support. Portion of this work was presented at the annual meeting of the American Association of Clinical Chemistry (AACC) July 2010, Los Angeles, USA.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Tamimi, W., Aljasser, S., Kanan, R. et al. Effects of hemoglobin S variants on the measurement of glycosylated hemoglobin A1c by four analytical methods. Int J Diabetes Dev Ctries 35, 392–399 (2015). https://doi.org/10.1007/s13410-014-0257-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13410-014-0257-0